Beschreibung
Extended molecular analysis data examining the effects of CBD-rich cannabis extract and MSM on cellular detoxification pathways. The results contribute to understanding the safety implications of co-supplementation.
More Figures from This Paper
Figure 6
Intrahepatic expression of cytochrome P450 enzymes in response to MSM, CBD-rich cannabis extract (CRCE), or their combination. Alterations in CYP450 expression are critical for assessing drug-supplement interaction potential and metabolic safety.
chart
Figure 7
Effects of MSM, CBD-rich cannabis extract, and their combination on intrahepatic glutathione synthesis and related gene expression. Glutathione is a key antioxidant, and changes in its production may indicate shifts in the liver's oxidative stress response.
chartFigure 5
Chart
698 × 561px
· 40,9 KB
Source Paper
Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration.Cite This Figure
 > Source: Kristy R Kutanzi et al. "Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Ext." *International journal of molecular sciences*, 2020. PMID: [33096940](https://pubmed.ncbi.nlm.nih.gov/33096940/)
<figure> <img src="https://pdfs.citedhealth.com/figures/33096940/93.png" alt="Extended molecular analysis data examining the effects of CBD-rich cannabis extract and MSM on cellular detoxification pathways. The results contribute to understanding the safety implications of co-supplementation." /> <figcaption>Figure 5. Extended molecular analysis data examining the effects of CBD-rich cannabis extract and MSM on cellular detoxification pathways. The results contribute to understanding the safety implications of co-supplementation.<br> Source: Kristy R Kutanzi et al. "Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Ext." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33096940/">33096940</a></figcaption> </figure>